Your session is about to expire
← Back to Search
Other
Integrated care van (ICV) for HIV/AIDS
N/A
Waitlist Available
Led By Gregory M Lucas, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up between 6 months prior to and the v7 follow-up visit at 7 months
Awards & highlights
Study Summary
This study is evaluating whether a van that provides services to people who inject drugs can improve clinical outcomes, be sustainable, and be cost-effective.
Eligible Conditions
- HIV/AIDS
- Intravenous Drug Use
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ between 6 months prior to and the v7 follow-up visit at 7 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between 6 months prior to and the v7 follow-up visit at 7 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Composite PWID Score (Service Access, Risk Behaviors, Adverse Outcomes)
Secondary outcome measures
Emergency Department (ED) Use
HCV Care Continuum
HCV Seroconversion
+13 moreOther outcome measures
Costs and Cost Effectiveness
Qualitative Assessments
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Integrated care van (ICV)Experimental Treatment1 Intervention
ICV visits neighborhoods served by the mobile syringe service program weekly. ICV provides a range of services targeted to people who inject drugs - HIV testing, HCV testing, PrEP, MAT, wound care, case work services, on-site medical management and linkage.
Group II: ControlActive Control1 Intervention
No additional services provided.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,263 Previous Clinical Trials
14,822,445 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,469 Previous Clinical Trials
2,618,689 Total Patients Enrolled
Baltimore City Health DepartmentOTHER
7 Previous Clinical Trials
18,280 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger